CAMP Q2 2025 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$1M100.0% margin

Operating Income

-$13M-870.3% margin

Net Income

-$13M-840.8% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

+74.5%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$51M

Total Liabilities

$11M

Stockholders' Equity

$40M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$13M	-$13M	-2.9%
Net Income	-$13M	-$13M	-0.1%